SBC Medical Group Holdings, Inc. (SBC)
NASDAQIndustrialsConsulting ServicesSnapshot 2026-09-04
$4.12-3.74%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsConsulting ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · SBC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -55.6% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 13.2% |
Growth built into the price is above our model estimate.
The price assumes 68.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 9 industry peers · Company calendar date is not available
SBC — earnings miss
Dated 2026-08-13
Results of Operations and Financial Condition. On August 13, 2026, SBC Medical Group Holdings Incorporated (the “Company”) issued a press release announcing its results for the quarter ended June 30, 2026. The press release is attached as Exhibit 99.1 and is incorporated herein by reference. The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or o…
Why it matters: Progress on this program shows management wants to give value back to shareholders.
Supportive ifManagement announces the start of the $20M share repurchase program.
Worry ifNo updates or delays on the share repurchase program are reported.
Why it matters: Maintaining net income above this level shows SBC is on track with its financial goals. It reflects overall business health.
Supportive ifNet income reported above $10M for Q2.
Worry ifNet income reported below $10M for Q2.
Why it matters: Hitting this target would show that SBC Medical's AI plans work. It would help revenue growth.
Supportive ifService fees from AI projects reach or exceed $15 million each year.
Worry ifService fees from AI projects are below $10 million. This shows problems with AI plans.
Why it matters: Success in this market could drive significant growth for SBC. It is a key priority for management.
Supportive ifManagement says they formed a partnership or made a purchase in the U.S. medical aesthetics market.
Worry ifNo progress or negative news regarding U.S. market entry.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$169 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $552 loss on $10,000 · 5.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,248 loss on $10,000 · 42.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A slowdown in customer growth could signal weakening demand for SBC's services.
Worry ifCustomer growth rate reported below 10% year over year.
Less concerning ifCustomer growth rate remains at or above 10% year over year.
Why it matters: A good resolution would help restore trust in SBC's listing compliance.
Supportive ifLook for an announcement that shows SBC follows Nasdaq rules for independence.
Worry ifMore notices or actions from Nasdaq about delisting.
Why it matters: Keeping a positive net income is important for SBC's finances. It helps investor confidence.
Worry ifQ2 2026 net income remains positive and shows improvement from Q1 2026.
Less concerning ifQ2 2026 net income declines further from Q1 2026's $11.3M.
Why it matters: A bigger drop in revenue shows ongoing problems. This can hurt investor confidence.
Worry ifQ2 revenue reports a decline worse than -9% year over year.
Less concerning ifQ2 revenue shows a decline less than or stabilizes year over year.
Why it matters: If revenue growth picks up, it could signal a recovery for SBC and its peers.
Supportive ifThree-year revenue growth in the industrial sector rises above 7%.
Worry ifThree-year revenue growth stays below 5%.
Why it matters: Growth in this area shows if SBC is making progress in a key market. A strong increase signals success in expansion efforts.
Supportive ifU.S. medical aesthetics revenue grows more than 10% quarter over quarter.
Worry ifU.S. medical aesthetics revenue grows less than 5% quarter over quarter.
Why it matters: Earnings results will show SBC's financial health and its place in the market.
Watch forThe earnings report shows revenue growth or beats what analysts expected.
Also watch forThe earnings report shows falling revenue or does not meet analyst expectations.
Why it matters: Progress in these markets could enhance SBC Medical's growth and market presence.
Watch forManagement announces a new partnership or clinic opening in the U.S. or ASEAN.
Also watch forNo news on international expansion plans will come in the next quarter.
Why it matters: If growth exceeds 13%, it shows SBC is growing faster and its AI plan works.
Supportive ifQ3 revenue growth is over 13% compared to last year.
Worry ifQ3 revenue growth falls below 13% year-over-year.
Why it matters: A net income margin above 22% shows strong profits and good cost control.
Supportive ifNet income margin stays above 22% in Q3.
Worry ifNet income margin drops below 22% in Q3.
Why it matters: Fixing Nasdaq compliance issues is key to keeping SBC's listing and investor trust.
Worry ifSBC resolves the Nasdaq compliance issue and maintains its listing.
Less concerning ifSBC faces delisting from Nasdaq.